Funder: [National Institutes of Health - https://www.nih.gov]
Due Dates: February 5, 2024 | June 5, 2024 | October 5, 2024 (Standard NIH R01 due dates)
Funding Amounts: Application budgets are not limited but must reflect project needs; maximum project period is 5 years.
Summary: Supports basic research to elucidate how the human microbiome modulates anti-tumor immune responses and to identify novel molecular targets for cancer prevention.
Key Information: Clinical trials are not allowed; applications must rigorously address parameters like concentration, timing, and duration of beneficial microbes; foreign institutions are eligible.